Krystal Biotech buy Cantor Fitzgerald
Start price
20.02.25
/
50%
€178.75
Target price
20.02.26
€205.35
Performance (%)
16.70%
Price
12.12.25
€208.60
Summary
This prediction is currently active. The BUY prediction by Cantor_Fitzgerald currently has a performance of 16.70%. This prediction currently runs until 20.02.26. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 3.678% | 3.678% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $215.00 price target on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€105.00
13.12.23
13.12.23
€166.84
13.12.24
13.12.24
47.38%
14.12.24
14.12.24
Krystal Biotech
Start price
Target price
Perf. (%)
€103.00
07.11.23
07.11.23
€149.84
07.11.24
07.11.24
75.83%
08.11.24
08.11.24